H0RSHOLM, Denmark--(BUSINESS WIRE)--LifeCycle Pharma A/S (OMX:LCP) today announced that clinical data from the LCP-AtorFen phase II study will be presented on November 11, 2008, at the American Heart Association’s 2008 Scientific Sessions in New Orleans during the Poster Presentation which takes place at 3:00-4:30 PM, Hall A-B1, APS.95.1.
